Blood in Stool: Labs, Causes, and Next Steps

What the Color of Your Stool Blood Actually Means

The color of rectal bleeding is your first and fastest diagnostic clue. Bright red blood (hematochezia) signals a source at or below the sigmoid colon because the transit time is short enough that hemoglobin does not oxidize. Black, tarry, foul-smelling stool (melena) forms when hemoglobin is digested during a prolonged transit from the esophagus, stomach, or proximal small intestine. A dark maroon or burgundy color often points to the right colon or small bowel.

A 2021 review in the American Journal of Gastroenterology confirmed that melena correctly predicts an upper GI source in roughly 90% of presentations, while hematochezia predicts a lower GI source in about 85% of cases [1].

Hematochezia (Bright Red or Maroon)

Bright red blood coating the outside of a stool, dripping into the toilet bowl, or visible on tissue paper is almost always from the left colon, rectum, or anus. Hemorrhoids account for the majority of these visits. Anal fissures, diverticular bleeding, ischemic colitis, and rectal cancer complete the short list of frequent culprits. Diverticular bleeding, notably, can be brisk enough to cause hemodynamic instability even though the diverticula themselves are benign outpouchings.

Melena (Black, Tarry Stool)

Melena requires at least 50 to 100 mL of blood in the upper GI tract and a transit time long enough for bacterial degradation of hemoglobin to hematin [2]. Peptic ulcer disease is the single most common upper GI source, responsible for roughly 40% of upper GI bleeds in a 2020 systematic review published in The Lancet [3]. Esophageal varices from cirrhosis, Mallory-Weiss tears, and erosive gastritis round out the leading causes. Bismuth-containing antacids and iron supplements can also blacken stool without any bleeding, so a medication history always accompanies the physical exam.

Occult Blood (No Visible Color Change)

Occult GI bleeding produces no visible color change. The stool appears completely normal. Detection requires a fecal occult blood test (FOBT) or a fecal immunochemical test (FIT). The U.S. Preventive Services Task Force recommends colorectal cancer screening starting at age 45 for average-risk adults, and annual FIT is one of three accepted first-line strategies [4].

Common Causes of Blood in Stool

Hemorrhoids

Internal hemorrhoids are the most frequently identified cause of rectal bleeding in primary care. They bleed when engorged venous plexuses in the anal canal rupture during defecation. Blood is typically bright red, painless, and limited to streaks on toilet paper or drips in the bowl. A 2019 prospective study (N=1,034) in Diseases of the Colon and Rectum found that hemorrhoids accounted for 44% of lower GI bleeding referrals in adults under 60 [5].

Anal Fissures

Fissures are small tears in the anoderm, usually in the posterior midline. They cause bright red blood with sharp, burning pain during and after defecation. The pain often distinguishes fissures from hemorrhoids, which are typically painless. First-line treatment is topical nitroglycerin 0.2% ointment or diltiazem 2% gel along with fiber supplementation to 25 to 35 grams per day.

Diverticular Disease

Diverticula affect approximately 35% of adults over age 60 in the United States [6]. Most diverticular bleeds stop spontaneously (75 to 80% of cases), but rebleeding occurs in about 25% of patients within one year. The bleed is typically painless, sudden, and heavy. A 64-slice CT angiogram, performed when active bleeding is suspected, can localize the source before colonoscopy or intervention.

Colorectal Cancer and Polyps

Colorectal cancer (CRC) caused an estimated 52,550 deaths in the U.S. In 2023 [7]. Bleeding from CRC is often occult and intermittent early in the disease; frank hematochezia or a change in stool caliber (pencil-thin stools) are late signs. Adenomatous polyps bleed intermittently and are premalignant. Every adult with unexplained iron-deficiency anemia warrants colonoscopy to exclude a bleeding polyp or cancer, per the American College of Gastroenterology (ACG) 2022 guidelines [8].

Inflammatory Bowel Disease

Ulcerative colitis (UC) and Crohn's disease both cause GI bleeding, though the character differs. UC typically produces bloody diarrhea with mucus. Crohn's more often causes occult bleeding or, when the colon is involved, frank hematochezia. A 2022 meta-analysis in Gut (N=12,347 IBD patients) found that 67% of UC flares presented with visible rectal bleeding at onset [9].

Peptic Ulcer Disease (Upper GI Source)

Helicobacter pylori infection and NSAID use together account for over 90% of peptic ulcers. A bleeding peptic ulcer typically presents with melena, though massive bleeds can cause bright red hematochezia due to rapid transit. Endoscopic findings are stratified by the Forrest classification. High-risk lesions (Forrest Ia, Ib, IIa) require endoscopic hemostasis and intravenous pantoprazole 80 mg bolus followed by an 8 mg/hour infusion for 72 hours, per ACG guidelines [10].

Less Common but Serious Causes

Angiodysplasia (arteriovenous malformations), mesenteric ischemia, small bowel tumors, aortoenteric fistula, radiation proctitis, and solitary rectal ulcer syndrome all present with rectal bleeding. Aortoenteric fistula deserves special mention: a "herald bleed," a small self-limited upper GI bleed in a patient with prior aortic surgery, should prompt emergency CT angiography and vascular surgery consultation.

When to Go to the Emergency Room

Some presentations of GI bleeding are immediately life-threatening. Go to the emergency room or call 911 if you have blood in the stool together with any of the following.

• Dizziness, lightheadedness, or fainting
• Heart rate above 100 beats per minute at rest
• Systolic blood pressure below 90 mmHg
• Blood clots larger than a quarter in the toilet
• Vomiting blood or material that looks like coffee grounds
• Severe abdominal pain

The AIMS65 score (albumin <3.0 g/dL, INR >1.5, altered mental status, systolic BP <90, age >65) predicts inpatient mortality from upper GI bleeding. A score of 2 or more carries a 14.3% inpatient mortality rate and warrants ICU-level monitoring [11].

The Diagnostic Workup: Labs and Imaging

A systematic approach to new-onset blood in stool prevents both under-investigation and unnecessary procedures.

First-Line Laboratory Tests

Complete Blood Count (CBC). The hemoglobin and hematocrit quantify blood loss. A hemoglobin <10 g/dL suggests significant chronic or acute loss. The mean corpuscular volume (MCV) distinguishes iron-deficiency anemia (microcytic, MCV <80 fL) from B12 or folate deficiency (macrocytic).

Comprehensive Metabolic Panel (CMP). Blood urea nitrogen (BUN) elevation out of proportion to creatinine (BUN:creatinine ratio >20:1) suggests an upper GI source because intestinal bacteria metabolize the blood protein load. A ratio >30:1 has a specificity of 87% for upper GI bleeding [12].

Coagulation Studies (PT, INR, aPTT). Coagulopathy drives bleeding in patients on warfarin, direct oral anticoagulants, or with liver disease. An INR above 1.5 significantly increases rebleeding risk.

Iron Studies. Serum ferritin <30 ng/mL confirms iron-deficiency anemia. Transferrin saturation below 16% and a low serum iron with elevated TIBC support this diagnosis.

Fecal Immunochemical Test (FIT). The FIT detects human globin in stool with a sensitivity of 79% and specificity of 94% for CRC, per a 2019 Cochrane systematic review (N=19 studies, 3.7 million participants) [13]. A positive FIT always requires follow-up colonoscopy.

H. Pylori Testing. Urea breath test or stool antigen test should be ordered for any patient with suspected peptic ulcer disease or upper GI bleeding. Eradicating H. Pylori reduces ulcer rebleeding risk by approximately 17-fold compared to acid suppression alone [14].

Imaging Studies

CT Angiography (CTA) of the Abdomen and Pelvis. CTA is the fastest way to localize active bleeding at a rate of at least 0.3 to 0.5 mL/min. Sensitivity approaches 86% for active lower GI bleeding. CTA should precede colonoscopy in hemodynamically unstable patients who cannot be prepped quickly.

Tagged Red Blood Cell (RBC) Scan. Nuclear medicine RBC scanning can detect bleeding rates as low as 0.1 mL/min over a 24-hour window. It lacks the spatial resolution of CTA but is useful for intermittent bleeds that were negative on CTA.

Abdominal X-Ray. Plain films add minimal value for GI bleeding unless perforation (free air under the diaphragm) or obstruction is suspected.

Endoscopic Evaluation

Upper Endoscopy (EGD). EGD is the test of choice for melena or suspected upper GI bleeding. It should be performed within 24 hours of presentation, or within 12 hours in high-risk patients (Forrest Ia or hemodynamic instability), per the 2021 ACG Clinical Guideline on Upper GI Bleeding [10].

Colonoscopy. Colonoscopy is the gold standard for evaluating lower GI bleeding, offering both diagnosis and therapy (hemostatic clipping, cauterization, or polypectomy) in a single procedure. The ACG recommends colonoscopy within 24 hours of hospitalization for brisk lower GI bleeding once the patient is hemodynamically stable and adequately prepped [8].

Flexible Sigmoidoscopy. Sigmoidoscopy examines only the rectum and sigmoid colon (roughly 60 cm). It is appropriate for isolated anorectal bleeding in patients under 50 with no family history of CRC, but misses right-sided pathology. Any patient over 45 with rectal bleeding and no definitive anorectal source on sigmoidoscopy needs full colonoscopy.

Capsule Endoscopy and Device-Assisted Enteroscopy. When upper endoscopy and colonoscopy are both negative, a small bowel source is suspected. Wireless capsule endoscopy examines the entire small intestine and has a diagnostic yield of 60 to 70% for obscure GI bleeding [15].

Treatment Approaches by Cause

Treatment targets the underlying source rather than the bleeding symptom.

Hemorrhoids and Fissures

Grade I to III hemorrhoids respond to office-based rubber band ligation in 75 to 80% of cases. Dietary fiber supplementation (psyllium 10 g/day) combined with sitz baths reduces symptoms and recurrence. Grade IV hemorrhoids and chronic fissures that fail topical therapy may require surgical hemorrhoidectomy or lateral internal sphincterotomy.

Peptic Ulcer Disease

Endoscopic hemostasis (injection of 1:10,000 epinephrine plus thermal coagulation or hemoclip placement) achieves initial hemostasis in 90 to 95% of Forrest I lesions. Post-endoscopy, oral proton pump inhibitors at standard doses (omeprazole 40 mg twice daily) reduce rebleeding risk by about 50% at 30 days compared to histamine-2 blockers [10]. H. Pylori eradication is confirmed by urea breath test 4 weeks after completion of therapy.

Diverticular Bleeding

Active diverticular bleeding is treated endoscopically with hemoclips or bipolar coagulation during colonoscopy. Refractory cases may require angiographic embolization or segmental colectomy. Aspirin and NSAIDs should be discontinued when clinically feasible; the relative risk of diverticular bleeding is approximately 2.6-fold higher in regular NSAID users [6].

Colorectal Cancer

Stage I CRC (confined to mucosa or submucosa) is treated with endoscopic resection or surgical resection and carries a 5-year survival rate above 90%. Stages II and III require surgical resection with or without adjuvant chemotherapy (FOLFOX or CAPOX regimens). Stage IV disease uses systemic chemotherapy, targeted therapy (bevacizumab, cetuximab depending on RAS/BRAF mutation status), and palliative care.

Inflammatory Bowel Disease

UC flares causing rectal bleeding are treated with mesalamine (5-ASA) suppositories 1 g/day for mild proctitis or oral mesalamine 4.8 g/day for more extensive disease, per the ACG IBD guidelines. Moderate to severe flares require intravenous corticosteroids or biologic agents such as infliximab 5 mg/kg at 0, 2, and 6 weeks.

Who Needs Colorectal Cancer Screening vs. A Diagnostic Workup

These two pathways are distinct and patients often confuse them.

Screening applies to asymptomatic average-risk adults aged 45 to 75. Options include annual FIT, stool DNA testing (Cologuard) every 1 to 3 years, or colonoscopy every 10 years.

Diagnostic workup applies to anyone with symptoms: visible rectal bleeding, unexplained iron-deficiency anemia, change in bowel habits lasting more than 4 weeks, or a positive FIT. Diagnostic colonoscopy is appropriate at any age when symptoms are present, and it is not subject to the 10-year screening interval.

The ACG 2021 guidance explicitly states that "a positive fecal test result should always prompt colonoscopy regardless of prior colonoscopy history" [8].

HealthRX Triage Framework: Blood in Stool

| Presentation | Urgency | First Action | |---|---|---| | Dizziness, HR >100, BP <90 | Emergency | Call 911 / ER now | | Melena without hemodynamic instability | Same-day/urgent | ER or urgent GI referral, EGD within 24h | | Bright red blood, age >45, no prior colonoscopy | Urgent (within 1 week) | CBC, FIT, GI referral for colonoscopy | | Bright red blood on paper only, age <45, prior normal colonoscopy | Semi-urgent (2 to 4 weeks) | Anorectal exam, trial of fiber/sitz baths, sigmoidoscopy if no improvement | | Positive FIT, asymptomatic | Elective but prompt (within 4 weeks) | Diagnostic colonoscopy |

Monitoring After Initial Treatment

Resolution of rectal bleeding does not end the workup. A repeat CBC 4 to 6 weeks after treatment confirms hemoglobin recovery. Iron supplementation (ferrous sulfate 325 mg three times daily) continues until ferritin exceeds 50 ng/mL. Post-polypectomy surveillance intervals depend on polyp histology: tubular adenomas <10 mm warrant repeat colonoscopy in 3 to 5 years; villous or high-grade dysplastic polyps require repeat at 1 year per the U.S. Multi-Society Task Force on Colorectal Cancer guidelines [16].

Patients treated for peptic ulcer disease undergo test-of-cure H. Pylori testing at 4 weeks, and a repeat EGD at 12 weeks is recommended for gastric ulcers to confirm healing and exclude malignancy.